Needham initiates GE HealthCare stock coverage with buy rating
Needham has initiated coverage on GE HealthCare Technologies Inc. (NASDAQ:GEHC) with a buy rating and a target price of $93.00. The current stock price is $64.81, with a P/E ratio of 14.96, indicating potential upside to the analyst's objective. The firm suggests that GE HealthCare’s capital book-to-bill correlation and capital growth outlook could propel accelerated AIS growth in 2027, potentially boosting Street models that currently only consider PCS growth.
The company's financial profile aligns with the median of large-cap peers, which the firm believes will lead to modest multiple expansion. Needham perceives the stock as undervalued based on its Fair Value analysis, in line with the bullish outlook. This move highlights the firm's belief that the current valuation does not fully account for the company’s growth potential in its capital equipment business.
The release of this information coincides with GE HealthCare’s impressive second-quarter earnings, recording $5.295 billion in revenue, a 3.5% year-over-year increase, and adjusted earnings per share of $1.13, surpassing analyst expectations. Strong organic orders, up 11.1%, have also contributed to the company's robust momentum, marking the fastest growth rate since the spin-off.
Other analysts, including BTIG and Mizuho, have also increased their price targets for GE HealthCare, citing strong orders and the company’s overall positive outlook. FDA clearance and CE Mark approval for GE HealthCare’s Photonova Spectra, a next-generation photon-counting CT system, further underscore the company’s growth prospects.
These developments point to GE HealthCare’s robust business operations and positive market momentum.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
